Sirius Medical

Sirius Medical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $12M

Overview

Sirius Medical is a private, commercial-stage medical device company focused on oncology surgery. Its core product, the Sirius Pintuition® system, uses a tiny implanted magnetic marker and a handheld detection probe with GPSDetect™ software to navigate surgeons to tumors during breast-conserving lumpectomies. The company has achieved EU MDR certification and US FDA clearance, established key commercial partnerships, and is actively expanding its global presence. Its technology addresses the limitations of traditional wire localization, aiming for better surgical precision, cosmetic results, and workflow efficiency.

OncologyBreast Cancer

Technology Platform

Surgical Marker Navigation platform consisting of an implantable permanent magnetic marker, a handheld multi-sensor detection probe, and GPSDetect™ software providing real-time audio/visual guidance for tumor localization during surgery.

Funding History

2
Total raised:$12M
Series A$10M
Seed$2M

Opportunities

Large and growing market shift from wire-guided to advanced tumor localization in breast-conserving surgery.
Potential to expand the magnetic marker navigation platform into other soft-tissue oncology procedures, such as lymph node or lung nodule surgery.
Strong value proposition for hospital efficiency and value-based care models.

Risk Factors

Faces competition from established alternative localization technologies (e.g., radioactive seeds, radar).
Adoption depends on surgeon training and securing favorable reimbursement codes in key markets like the US.
Future growth is tied to successful clinical and commercial execution in new therapeutic areas beyond breast cancer.

Competitive Landscape

Competes in the advanced tumor localization market against technologies like radioactive seed localization (e.g., Savi Scout) and radar-based systems (e.g., LOCalizer). Must displace the entrenched, lower-cost standard of wire-guided localization. Competitive advantages include no radiation, flexible pre-operative placement, and intuitive multi-sensory guidance.